Navigation Links
Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
Date:9/18/2008

he same site as Inner Mongolia's 2,000 TPA production facility. The new facility is now scheduled to be completed by the middle of October 2008 and to be fully operational in the first quarter of 2009, which will increase our potential production capacity a total of 400%.

Rich Pipeline of New Products

We are developing a number of new nutrient products that target specific plants and animals. We currently produce a universal plant nutrient product. The Company is developing specialized products that will target corn, la jiao peppers, wheat, rice, cucumbers, tomatoes, cotton, potatoes, sunflowers, grapes, tropical fruits and flowers. Our animal nutrient product is for dairy cows. Specialized nutrient products are being developed that will focus on hogs, poultry and sheep. We expect to increase our sales revenue by targeting specific plant needs and providing nutrients to more types of livestock and will roll these out according to our market strategy.

Outstanding Financial Results

Our strong product portfolio and growing distribution footprint resulted in outstanding financial performance in the first half of 2008. Net revenue grew by 232.0% to $27.0 million in the six months ended June 30, 2008, up from $8.1 million in the six months ended June 30, 2007. Gross profit was $14.6 million in the same period, representing a gross margin of 54.0%, as compared to gross profit of $3.8 million, or a gross margin of 46.5%, in the six months ended June 30, 2007. Net income was $7.7 million, or $0.54 per diluted share, compared to $3.4 million, or $0.29 per diluted share, in the six months ended June 30, 2007. As in the first six months of 2008, we expect the remaining two quarters to conform to plan for 2008 and lead towards our net income "make good" target of $10.3 million which we provided to investors as part of both of our private placement transactions.

Upcoming Visit to the United States

In the second half of September, Yongye s
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
6. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
7. XTL Receives Staff Letter From NASDAQ
8. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
9. Pharmos Issues Letter to Shareholders
10. Coherent, Inc. Receives Expected Letter from NASDAQ
11. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Grace Century, a private equity consultancy ... the addition of Dr. Yousef “Josh” Siddiqui , ... Dr. Siddiqui will provide further healthcare expertise to its ... University College Medical School in the late ... 2001. With further certification as a General Practitioner (GP), ...
(Date:10/22/2014)... 22, 2014   Synthetic Biologics, Inc. (NYSE ... for serious infections and diseases, announced today that the ... of Allowance for a composition of matter patent application ... program, SYN-004. This is Synthetic Biologics, first allowed ... and adds to the Company,s extensive C. difficile ...
(Date:10/22/2014)... 22, 2014 Research and Markets  has ... by Material, by Application, Geography - Global Analysis and ... Organic electronics, also called as polymer ... science which deals with small conductive molecules and electrically ... molecules and polymers are carbon based, made using synthetic ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
Breaking Biology Technology:Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3
... March 10 Niusule Biotech Corp. (OTC Bulletin Board: ... Co., Ltd., has been formally established by obtaining the ... Investment in the People,s Republic of China" from Zhejiang ... 2009 and the Business License from Hangzhou Industrial and ...
... 10 The Center for,Translational Molecular Medicine ... the research and development of new techniques ... - today announced that eight,new research projects ... means that,almost 250 million Euros have now ...
... Lead Hong Kong-based subsidiary Pangu BioPharmaSAN DIEGO, March 10 ... on discovery and development of an entirely new class ... today announced that Dr. James Cai has joined the ... aTyr Pharma and President of Pangu BioPharma, a fully ...
Cached Biology Technology:Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the People's Republic of China 2Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the People's Republic of China 3Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease 2Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease 3Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia 2Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia 3
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/16/2014)... have a new synthesis of recent research findings to ... in the two states. , The Ecology and ... Washington: A Synthesis of the Relevant Biophysical Science and ... published by the U.S. Forest Service,s Pacific Northwest Research ... managers for a synthesis of the large body of ...
(Date:10/16/2014)... October 16, 2014 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... technologies including Wocket™, the Smart Wallet, at the 13 ... is a leading global conference on the intersection of ... Mark Anderson , founder and publisher of the ...
Breaking Biology News(10 mins):Sperm wars 2New report synthesizes best available science on management of moist mixed-conifer forests 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
... 16 November 2010 Elsevier ( www.elsevier.com ) ... medical information products and services, today announced the ... within the SciVerse platform that will empower the ... that advance the search and discovery process through ...
... Elsevier announced the winners of the 2010 Semantic ... the International Semantic Web Conference held in Shanghai, China ... leading experts from both academia and industry awarded the ... in total. The semantic web is an exciting ...
... days of critical international discussion and debate, led by ... Clinical Densitometry (ISCD) and the International Osteoporosis Foundation (IOF), ... pertaining to the interpretation and use of FRAX in ... Tool (FRAX), with models for some 26 countries, is ...
Cached Biology News:Elsevier launches SciVerse Applications beta 2Elsevier launches SciVerse Applications beta 3Elsevier sponsors 2010 Semantic Web Challenge 2Elsevier sponsors 2010 Semantic Web Challenge 3International discussions on FRAX smooth the way for implementation in clinical practice 2
... Ascent is the first nephelometer ... microplates. Nepheloskan measures light scattering ... for particle quantification. This makes ... in drug discovery, immunoprecipitation, and ...
... Form: White powder Assay: 1.5 - 2.0 Bleomycin units/mg Identity ... On Drying: less than or equal to 6.0% Copper (Cu): ... : 55 - 70% B 2 : 25 - 32% ... to 90% B 4 : less than or equal to ...
... deliver critical performance for all vacuum requirements. ... pump performance to suit all applications. The ... checking of proper oil levels at a ... designed to work with all Thermo Savant ...
6 x Blend of rTth DNA Polymerase and Tli to provide optimized amounts of both 5-3 and 3-5 proofreading activity...
Biology Products: